[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].
Ishikawa
Naoyoshi
N
Institute of Medical Sciences, Department of Medicine, Tokai University School of Medicine.
Miyata
Toshio
T
Kurokawa
Kiyoshi
K
D000577:Amides / Q000494:pharmacology / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000209:etiology; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000209:etiology; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors*; D006146:Guanidines / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology / Q000627:therapeutic use; D006834:Hydrazines / Q000494:pharmacology / Q000627:therapeutic use; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use; D000068557:Olmesartan Medoxomil; D018384:Oxidative Stress / Q000187:drug effects; D011733:Pyridoxamine / Q000494:pharmacology / Q000627:therapeutic use; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use
D000577:Amides; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D017127:Glycation End Products, Advanced; D006146:Guanidines; D006834:Hydrazines; D007093:Imidazoles; D013777:Tetrazoles; D006830:Hydralazine; D011733:Pyridoxamine; D000068557:Olmesartan Medoxomil; C468887:ALT-946; C004479:pimagedine